home / stock / afmd / afmd articles

AFMD Articles, Affimed N.V.

Stock Information
Company Name: Affimed N.V.
Stock Symbol: AFMD
Market: NASDAQ
Website: affimed.com
Menu
AFMD AFMD Quote AFMD Short AFMD News AFMD Articles AFMD Message Board
Get AFMD Alerts

News, Short Squeeze, Breakout and More Instantly...
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024 | Benzinga

MANNHEIM, Germany, June 05, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving pa...
Why Is German Biotech Affimed Stock Soaring On Monday? | Benzinga

Affimed N.V. (NASDAQ:AFMD) shares are trading higher on Monday. On Saturday, the company announced longer follow-up data from the EGFRwt ...

Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results. SAIC reported a 9% ...

Why Affimed Shares Are Soaring | Benzinga

Affimed N.V. (NASDAQ:AFMD) shares are trading higher Monday after the company announced additional follow-up data from the on-going AFM24-102 study...
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort | Benzinga

In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieve...

Affimed Announces Annual General Meeting of Shareholders | Benzinga

MANNHEIM, Germany, May 28, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"), a clinical-stage immuno-oncology c...

Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024 | Benzinga

In 15 response-evaluable patients with metastatic EGFR wild-type NSCLC, who were pretreated with platinum doublet chemotherapy and checkpoint inh...
Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress | Benzinga

Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML...

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. United Natural F...

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The com...
Next 10